Stay informed and ready to meet both everyday challenges and long-term planning and policy-making goals, with focused news, practical information, and strategic insights on all HR-related developments.
Jan. 12 — One-third of U.S. workers hesitate to call in sick to work when they are ill, consumer product manufacturer Procter & Gamble found in a recent survey.
“We were surprised to see just how many U.S. respondents were reluctant to call in sick when experiencing a cold or flu,” Dave Tomasi, North American marketing director for the company's Vicks brand over-the-counter cold medicines, said in a Jan. 8 statement. No less than 334 out of the 1,000 U.S. respondents felt that way, a company spokesperson said in a Jan. 12 e-mail to Bloomberg BNA.
“The leading motive for deciding not to take a sick day, as reported by respondents, was work pressures (44.9 percent),” followed by “financial concerns (42.5 percent) and fear of falling behind at the office (33.5 percent),” the company said.
The opt-in survey was conducted for P&G by Survey Monkey in two waves from April to July 2014, with 15,000 responses collected from 15 countries: the U.S., Germany, France, Spain, Italy, Russia, Poland, Ukraine, Hungary, India, Indonesia, China, Mexico, Australia and Brazil.
“The influenza virus circulating this year has mutated, and federal officials have warned that this year's vaccine may not provide as much protection—this has a lot of people very nervous,” Vicks spokesperson Nurse Barb Dehn said in the Jan. 8 statement.
“I recommend that sick patients get plenty of rest at home, if they can, to limit the spread of the virus,” Dehn added. “As always, consult with your health care provider.”
To contact the reporter on this story: Martin Berman-Gorvine in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Simon Nadel at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)